Belluscura 将 TMT Acquisition 的股份增至 90.81%，最终完成价值 580 万英镑的全股权收购交易。 Belluscura increases stake in TMT Acquisition to 90.81%, finalizing an all-share takeover deal worth £5.8M.

在收购要约完全无条件后，Belluscura 将其在 TMT Acquisition 中的股份增至 90.81%。 Belluscura has increased its stake in TMT Acquisition to 90.81% after its takeover bid became wholly unconditional. 此前，上个月达成了全股收购条款协议。 This follows an agreement of terms for an all-share offer last month. 这家在伦敦上市的医疗设备开发商目前拥有 TMT Acquisition 的 2500 万股股票，这是一家专门从事技术、媒体和电信采购的公司。 The London-listed medical device developer now owns 25 million shares of TMT Acquisition, a company specializing in technology, media, and telecom purchases. 此次收购是在 Belluscura 在 10 月份宣布同意以价值 580 万英镑的全股交易收购 TMT Acquisition 后进行的。 The takeover comes after Belluscura's announcement in October, agreeing to buy TMT Acquisition in an all-share deal valued at £5.8 million.